by MM360 Staff | Jun 24, 2025 | Uncategorized
Source: CureToday articles Dr. Joshua Sabari and Dr. Nausheen Ahmed sat down to discuss topline takeaways in the realm of hematologic malignancies following the 2025 ASCO Meeting. Read More
by MM360 Staff | Jun 17, 2025 | Myeloma News
Source: Myeloma : nature.com subject feeds Post Content Read More
by MM360 Staff | Jun 17, 2025 | Myeloma News
Source: Pharmacy Times articles Talquetamab and teclistamab showed significant promise in a phase 1b/2 dose escalation and expansion trial. Read More
by MM360 Staff | Jun 13, 2025 | Publications
Leuk Lymphoma. 2025 Jun 12:1-11. doi: 10.1080/10428194.2025.2512031. Online ahead of print. ABSTRACT THIS META-ANALYSIS OF EIGHT PHASE 3 RCTS ASSESSED EFFICACY AND SAFETY OF ANTI-CD38 MONOCLONAL ANTIBODIES (MABS) IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA...
by MM360 Staff | Jun 10, 2025 | Myeloma News
Source: Myeloma : nature.com subject feeds Post Content Read More
